Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00744380 · ClinicalTrials.gov registry record · NA
Dexmedetomidine Versus Midazolam for Facilitating Extubation
A NA study, sponsored by University of Colorado, Denver.
- Completed
- Registry status
- NA
- Development phase
- 23
- Enrollment target
NCT00744380 is a NA study that has completed, run by University of Colorado, Denver. The registered enrollment target is 23 participants.
The verdict
NCT00744380, a NA study, has completed, sponsored by University of Colorado, Denver.
- COMPLETED
- Registry status
- NA
- Development phase
- 23 participants
- Enrollment target
Study Summary
The purpose of this randomized, double-blind study is to evaluate the utility, safety, and cost of transitioning benzodiazepine sedation to dexmedetomidine in medical or surgical intensive care unit (ICU) patients requiring sedation when tracheal extubation is nearing. Fifty medical or surgical ICU patients requiring sedation with existing benzodiazepine therapy and qualifying for daily awakenings will be randomized in a double-blind manner to receive additional midazolam or dexmedetomidine.
Interventions
- DRUG Midazolam
- DRUG Dexmedetomidine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 23 participants |
| Start Date | 2008-08 |
| Est. Completion | 2012-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00744380
The ClinicalTrials.gov registry entry for NCT00744380 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 23 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Colorado, Denver, which has 1,283 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Midazolam is the first listed.
NCT00744380 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00744380 about?
NCT00744380 is a clinical study titled "Dexmedetomidine Versus Midazolam for Facilitating Extubation". The purpose of this randomized, double-blind study is to evaluate the utility, safety, and cost of transitioning benzodiazepine sedation to dexmedetomidine in medical or surgical intensive care unit (ICU) patients requiring sedation when tracheal extubation is nearing. Fifty medical or surgical ICU ...
What is the current status of trial NCT00744380?
This trial is currently completed. It is a NA study. The enrollment target is 23 participants. The study started on 2008-08. Estimated completion is 2012-10.
What interventions are being tested in trial NCT00744380?
The interventions under investigation include: Midazolam (DRUG), Dexmedetomidine (DRUG).
Who is sponsoring clinical trial NCT00744380?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.